Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003502554 | SCV004296379 | pathogenic | ALG1-congenital disorder of glycosylation | 2023-04-24 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 690318). This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 98 of the ALG1 protein (p.Pro98Leu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with congenital disorder of glycosylation type 1K (PMID: 23806237, 26931382). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ALG1 protein function. For these reasons, this variant has been classified as Pathogenic. |
University of Washington Center for Mendelian Genomics, |
RCV000851226 | SCV000993478 | likely pathogenic | Congenital disorder of glycosylation | 2017-05-25 | no assertion criteria provided | research |